一种治疗再生障碍性贫血的新药——再障生血片已经问世,经过浙江医科大学附属一院等医疗单位使用,效果良好。再生障碍性贫血是一种造血系统的常见疾病和疑难病,亚洲地区发病率较高,其发病率约为十万分之二至四。由于该病好发于青壮年,发病机制为造血机能障碍,导致贫血,治疗颇为棘手,多种治疗措施疗效不 A new drug for the treatment of aplastic anemia, Aplastic Blood Tablets, has been launched. It has been used by medical institutions such as the First Affiliated Hospital of Zhejiang Medical University. Aplastic anemia is a common and difficult disease of the hematopoietic system. The incidence in Asia is relatively high, and the incidence rate is about 100,000 to 40,000. Because the disease occurs in young adults, the pathogenesis is hematopoietic dysfunction, resulting in anemia, the treatment is quite tricky, and the efficacy of multiple treatment measures is not